Hemanext

Series-B+
hemanext.com Biotech & Healthcare
Total Funding $18M
Latest Round $18M Series-B+
Last Announced Nov 9, 2022
Investors Undisclosed
Decision Makers 6 Verified

About Hemanext

Hemanext is dedicated to improving transfusion care by preserving the vitality of red blood cells through oxygen-controlled storage.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B+
Global Headquarters Undisclosed
Tracked Since Oct 1, 2026

Web & Domain Identity

Official Website hemanext.com
Domain Registered Date Aug 11, 2006

Social & Network Presence

X / Twitter Profile @Hemanext_Inc (96 followers) Created on Oct 2019
LinkedIn Corporate Not linked

Company Milestones & Timeline

4 Events
  1. Capital Raise

    Raised $18,000,000 · Series-B+

    startupintros.com

  2. Capital Raise

    Series-A announced

    fundraisingfox.com

  3. Milestone

    X account created (@Hemanext_Inc)

    96 followers

  4. Milestone

    Website domain registered

    hemanext.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Hemanext.

Funding History

2 Rounds
Series-B+ · Nov 9, 2022
Series-A · Sep 30, 2021

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts